| Ashu Kudesia, MD | |
|
1260 E Woodland Ave, Suite 200, Springfield, PA 19064-3969 | |
| (610) 690-4471 | |
| (610) 690-4474 |
| Full Name | Ashu Kudesia |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 8 Years |
| Location | 1260 E Woodland Ave, Springfield, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1578913620 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MD470427 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Crozer Chester Medical Center | Upland, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prospect Health Access Network Inc | 5698065142 | 196 |
News Archive
A hearty dose of Mother Nature may be an effective antidote for many physical and psychological ailments, several studies have suggested. However, no one has calculated how much green - as in dollars - nature's greenery saves on health care costs.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
In humans, active periods of the debilitating disease Multiple Sclerosis (MS) can last for mere minutes or extend to weeks at a time. They're caused by lesions in the brain that develop, partly heal, and then recur. Research into a cure has been difficult, because to date scientists have not been able to replicate these brain recurring symptoms in laboratory mice. That's frustrating because these lab animals, known as animal "models," are the primary tool for research into the mechanisms and potential treatments for MS.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Entity Name | Prospect Health Access Network Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568819084 PECOS PAC ID: 5698065142 Enrollment ID: O20160613000737 |
News Archive
A hearty dose of Mother Nature may be an effective antidote for many physical and psychological ailments, several studies have suggested. However, no one has calculated how much green - as in dollars - nature's greenery saves on health care costs.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
In humans, active periods of the debilitating disease Multiple Sclerosis (MS) can last for mere minutes or extend to weeks at a time. They're caused by lesions in the brain that develop, partly heal, and then recur. Research into a cure has been difficult, because to date scientists have not been able to replicate these brain recurring symptoms in laboratory mice. That's frustrating because these lab animals, known as animal "models," are the primary tool for research into the mechanisms and potential treatments for MS.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ashu Kudesia, MD 1260 E Woodland Ave Ste 200, Springfield, PA 19064-3956 Ph: (610) 690-4490 | Ashu Kudesia, MD 1260 E Woodland Ave, Suite 200, Springfield, PA 19064-3969 Ph: (610) 690-4471 |
News Archive
A hearty dose of Mother Nature may be an effective antidote for many physical and psychological ailments, several studies have suggested. However, no one has calculated how much green - as in dollars - nature's greenery saves on health care costs.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
In humans, active periods of the debilitating disease Multiple Sclerosis (MS) can last for mere minutes or extend to weeks at a time. They're caused by lesions in the brain that develop, partly heal, and then recur. Research into a cure has been difficult, because to date scientists have not been able to replicate these brain recurring symptoms in laboratory mice. That's frustrating because these lab animals, known as animal "models," are the primary tool for research into the mechanisms and potential treatments for MS.
A research team at Montefiore Health System and Albert Einstein College of Medicine led by Alain Litwin, M.D., was awarded $14 million by the Patient-Centered Outcomes Research Institute (PCORI) to determine how best to treat hepatitis C among people who inject drugs (PWID), a group with a high rate of infection.
› Verified 7 days ago
Dr. Brandon Gregory Twombly, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1260 E Woodland Ave Ste 200, Springfield, PA 19064 Phone: 610-690-4490 | |
Dr. Nimshavathani Thaver, D.O. Family Medicine Medicare: Medicare Enrolled Practice Location: 1260 E Woodland Ave, Suite 200, Springfield, PA 19064 Phone: 610-690-4490 Fax: 610-328-9391 | |
Letitia Ann O'kicki, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1260 E Woodland Ave, Suite 200, Springfield, PA 19064 Phone: 610-690-4490 Fax: 610-328-9391 | |
Nicole Ferraro, DO Family Medicine Medicare: Medicare Enrolled Practice Location: 1260 E Woodland Ave Ste 200, Springfield, PA 19064 Phone: 610-690-4900 | |
Larisa Cheipesh, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 965 Baltimore Pike, Suite 2b, Springfield, PA 19064 Phone: 484-573-5116 Fax: 484-573-5122 | |
Dr. Sarah Morchen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1260 E Woodland Ave, Suite 200, Springfield, PA 19064 Phone: 610-690-4490 Fax: 610-328-9391 | |
Dr. William J Warning Ii, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1260 E Woodland Ave, Springfield, PA 19064 Phone: 610-690-4490 Fax: 610-328-9391 |